MPN Congress 2022 | Novel mutations in PV & the importance of understanding their role in disease initiation
Josef Prchal
• 24 Oct 2022
Josef Prchal, MD, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, highlights the importance of identifying mutations associated with polycythemia vera (PV) and understanding how they may lead to disease initiation and progression. Prof. Prchal describes two studies that are investigating two novel mutations that are thought to be involved in PV. This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
